Nutrition 21 2Q Sales Stumble

Nutrition 21 2Q Sales Stumble

PURCHASE, N.Y.Nutrition 21 Inc. (NASDAQ:NXXI) reported secondquarter net sales of $2.0 million, down from $2.6 million sold in the samequarter last year, which also benefited from a one-time income payment of $1million. Net income also dipped, worsening to a loss of $3.1 million or $0.08per diluted share from $0.3 million or $0.01 per diluted share lost the yearprior.

The net loss for the quarter reflects recent management changes and thecontinuing shift of our resources to support the sale of our proprietaryChromax® and Diachrome® branded products directly to retailers, said PaulIntlekofer, chief operations officer (COO) and chief financial officer (CFO).Our major clinical investments for Chromax and Diachrome have impressedhealthcare professionals and retailers. Our initial efforts in this directionhave been validated by a commitment we have received from Rite Aid.